Professional Compounding Centers of America

Professional Compounding Centers of America Political Action Committee

Corporate PAC FEC C00558452

Influence at a glance · Jan 2025 – Sep 2026Jan 25 – Sep 26 How we count

PAC giving to candidates$141K

Company lobbying, all issues $1.3M

Giving: FEC filings, net of refunds. Lobbying: the company’s own LD-2 reports, all issues, rounded to the nearest $10,000 each quarter. Two different filers, same 21 months.Lobbying: all issues, rounded to the nearest $10,000. Two filers, same 21 months. This PAC gives money raised from the company’s employees; the company itself can’t give to campaigns from its treasury.

Lobbying spend by quarter since 2015Spend by quarter Pro

Free account See Pro

What they lobby on

Method

Professional Compounding Centers of America reported federal lobbying in 8 of the last 8 quarters (Q4 2024 to Q3 2026), with its own in-house lobbyists and 3 outside firms. What follows is what the filings say it lobbied on, not which way.

Issue areas ranked by quarters filedQ4 24 → Q3 26

Budget/Appropriations8 of 88/8
Health Issues8 of 88/8
Medicare/Medicaid8 of 88/8
Pharmacy8 of 88/8

Bills named in the filings 9 bills, this period

H.R. 5316 Drug Shortage Compounding Patient Access Act of 20255 filings
H.R. 6509 SAFE Drugs Act of 20253 filings
S. 3788 / H.R. 8269 CLEAR LABELS Act3 filings
S. 3794 SAFE Drugs Act of 20263 filings
H.R. 167, 118th Patient Access to Urgent-Use Pharmacy Compounding Act of 20232 filings

4 more, 3 named in only one filing · Show all 9

H.R. 3810, 118th Drug Origin Transparency Act of 20232 filings
H.R. 167 Community Reclamation Partnerships Act of 20251 filing
H.R. 3810 SKIM Act1 filing
H.R. 8749, 118th Safer Compounding in Hospitals Act of 20241 filing

From the filings

“Issues related to implementation of the Drug Quality and Security Act, issues related to animal drug compounding, issues relating to opioid safety; issues related to the pharmaceutical supply chain; issues related to drug shortages; H.R. 5316, the Drug Shortage Compounding Patient Access Act of 2025”

Q4 2025 filing · Pharmacy

“Monitoring Healthcare Regulations and Legislation”

Q3 2026 filing · Health Issues

Contacted as listed on the filings

U.S. House
U.S. Senate
Centers For Medicare and Medicaid ServicesCMS
Food & Drug AdministrationFDA
Health & Human ServicesHHS

The House and Senate appear in every quarter; agencies in all 8 quarters.

Every filing since 2015, with the lobbyists named and the quarters each bill appearsEvery filing since 2015 Pro

Free account See Pro

Source: Lobbying Disclosure Act filings (LD-2) by Professional Compounding Centers of America, Senate Office of Public Records. Filings are due 20 days after each quarter ends.

From FEC filings: direct gifts this PAC reported, net of refunds · How we count

Gave directly to 49 sitting members of Congress and 6 other candidates in 2025–26.

Everyone this PAC fundsPro

See every candidate and member Professional Compounding Centers of America gave to directly, how much, and how its money splits between the parties.

This part is in Pro. A free account lets you follow up to 3 people and get a weekly email about them; upgrade whenever you need more.

Create a free account See what Pro adds Log in